Treatment of ocular hypertension with class I calcium channel blocking agents
US4981871A · kind A · utility
74Cited by
2References
8Claims
0Family size
Inventor
Key dates
| Filing date | May 15, 1987 |
| Grant date | Jan 1, 1991 |
| Priority date | — |
| Expiry date | May 15, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Elevated intraocular pressure in a mammalian eye is lowered by administering to the eye an amount of a Class I calcium channel blocking agent effective to lower the elevated intraocular pressure. A preferred calcium channel blocking agent is verapamil and the preferred mode of administration is topical directly to the eye, e.g., with drops.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.